img

Global Small Molecule Drug CDMO Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Small Molecule Drug CDMO Market Research Report 2024

A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fieldsproduct development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
According to MRAResearch’s new survey, global Small Molecule Drug CDMO market is projected to reach US$ 41580 million in 2033, increasing from US$ 27840 million in 2022, with the CAGR of 5.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Small Molecule Drug CDMO market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Small Molecule Drug CDMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Lonza
Catalent
Thermo Fisher Scientific
Samsung Biologics
Fareva
WuXi AppTech
WuXi Biologics
Siegfried
FUJIFILM Diosynth Biotechnologies
Asymchem
Pfizer CentreOne
Delpharm
Recipharm
AGC Pharma Chemicals
Boehringer Ingelheim
Vetter
Curia
Aenova
Porton
Segment by Type
FDF CDMO
Packaging CDMO
Clinical CDMO

Segment by Application


Pharmaceutical Company
Biotechnology Company
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Small Molecule Drug CDMO report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Drug CDMO Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 FDF CDMO
1.2.3 Packaging CDMO
1.2.4 Clinical CDMO
1.3 Market by Application
1.3.1 Global Small Molecule Drug CDMO Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Drug CDMO Market Perspective (2018-2033)
2.2 Small Molecule Drug CDMO Growth Trends by Region
2.2.1 Global Small Molecule Drug CDMO Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Small Molecule Drug CDMO Historic Market Size by Region (2018-2023)
2.2.3 Small Molecule Drug CDMO Forecasted Market Size by Region (2024-2033)
2.3 Small Molecule Drug CDMO Market Dynamics
2.3.1 Small Molecule Drug CDMO Industry Trends
2.3.2 Small Molecule Drug CDMO Market Drivers
2.3.3 Small Molecule Drug CDMO Market Challenges
2.3.4 Small Molecule Drug CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Drug CDMO Players by Revenue
3.1.1 Global Top Small Molecule Drug CDMO Players by Revenue (2018-2023)
3.1.2 Global Small Molecule Drug CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Small Molecule Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Small Molecule Drug CDMO Revenue
3.4 Global Small Molecule Drug CDMO Market Concentration Ratio
3.4.1 Global Small Molecule Drug CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Drug CDMO Revenue in 2022
3.5 Small Molecule Drug CDMO Key Players Head office and Area Served
3.6 Key Players Small Molecule Drug CDMO Product Solution and Service
3.7 Date of Enter into Small Molecule Drug CDMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Drug CDMO Breakdown Data by Type
4.1 Global Small Molecule Drug CDMO Historic Market Size by Type (2018-2023)
4.2 Global Small Molecule Drug CDMO Forecasted Market Size by Type (2024-2033)
5 Small Molecule Drug CDMO Breakdown Data by Application
5.1 Global Small Molecule Drug CDMO Historic Market Size by Application (2018-2023)
5.2 Global Small Molecule Drug CDMO Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Small Molecule Drug CDMO Market Size (2018-2033)
6.2 North America Small Molecule Drug CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Small Molecule Drug CDMO Market Size by Country (2018-2023)
6.4 North America Small Molecule Drug CDMO Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Drug CDMO Market Size (2018-2033)
7.2 Europe Small Molecule Drug CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Small Molecule Drug CDMO Market Size by Country (2018-2023)
7.4 Europe Small Molecule Drug CDMO Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Drug CDMO Market Size (2018-2033)
8.2 Asia-Pacific Small Molecule Drug CDMO Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Small Molecule Drug CDMO Market Size by Region (2018-2023)
8.4 Asia-Pacific Small Molecule Drug CDMO Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule Drug CDMO Market Size (2018-2033)
9.2 Latin America Small Molecule Drug CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Small Molecule Drug CDMO Market Size by Country (2018-2023)
9.4 Latin America Small Molecule Drug CDMO Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Drug CDMO Market Size (2018-2033)
10.2 Middle East & Africa Small Molecule Drug CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Small Molecule Drug CDMO Market Size by Country (2018-2023)
10.4 Middle East & Africa Small Molecule Drug CDMO Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Small Molecule Drug CDMO Introduction
11.1.4 Lonza Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Detail
11.2.2 Catalent Business Overview
11.2.3 Catalent Small Molecule Drug CDMO Introduction
11.2.4 Catalent Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.2.5 Catalent Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Small Molecule Drug CDMO Introduction
11.3.4 Thermo Fisher Scientific Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Detail
11.4.2 Samsung Biologics Business Overview
11.4.3 Samsung Biologics Small Molecule Drug CDMO Introduction
11.4.4 Samsung Biologics Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.4.5 Samsung Biologics Recent Development
11.5 Fareva
11.5.1 Fareva Company Detail
11.5.2 Fareva Business Overview
11.5.3 Fareva Small Molecule Drug CDMO Introduction
11.5.4 Fareva Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.5.5 Fareva Recent Development
11.6 WuXi AppTech
11.6.1 WuXi AppTech Company Detail
11.6.2 WuXi AppTech Business Overview
11.6.3 WuXi AppTech Small Molecule Drug CDMO Introduction
11.6.4 WuXi AppTech Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.6.5 WuXi AppTech Recent Development
11.7 WuXi Biologics
11.7.1 WuXi Biologics Company Detail
11.7.2 WuXi Biologics Business Overview
11.7.3 WuXi Biologics Small Molecule Drug CDMO Introduction
11.7.4 WuXi Biologics Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.7.5 WuXi Biologics Recent Development
11.8 Siegfried
11.8.1 Siegfried Company Detail
11.8.2 Siegfried Business Overview
11.8.3 Siegfried Small Molecule Drug CDMO Introduction
11.8.4 Siegfried Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.8.5 Siegfried Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Asymchem
11.10.1 Asymchem Company Detail
11.10.2 Asymchem Business Overview
11.10.3 Asymchem Small Molecule Drug CDMO Introduction
11.10.4 Asymchem Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.10.5 Asymchem Recent Development
11.11 Pfizer CentreOne
11.11.1 Pfizer CentreOne Company Detail
11.11.2 Pfizer CentreOne Business Overview
11.11.3 Pfizer CentreOne Small Molecule Drug CDMO Introduction
11.11.4 Pfizer CentreOne Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.11.5 Pfizer CentreOne Recent Development
11.12 Delpharm
11.12.1 Delpharm Company Detail
11.12.2 Delpharm Business Overview
11.12.3 Delpharm Small Molecule Drug CDMO Introduction
11.12.4 Delpharm Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.12.5 Delpharm Recent Development
11.13 Recipharm
11.13.1 Recipharm Company Detail
11.13.2 Recipharm Business Overview
11.13.3 Recipharm Small Molecule Drug CDMO Introduction
11.13.4 Recipharm Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.13.5 Recipharm Recent Development
11.14 AGC Pharma Chemicals
11.14.1 AGC Pharma Chemicals Company Detail
11.14.2 AGC Pharma Chemicals Business Overview
11.14.3 AGC Pharma Chemicals Small Molecule Drug CDMO Introduction
11.14.4 AGC Pharma Chemicals Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.14.5 AGC Pharma Chemicals Recent Development
11.15 Boehringer Ingelheim
11.15.1 Boehringer Ingelheim Company Detail
11.15.2 Boehringer Ingelheim Business Overview
11.15.3 Boehringer Ingelheim Small Molecule Drug CDMO Introduction
11.15.4 Boehringer Ingelheim Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.15.5 Boehringer Ingelheim Recent Development
11.16 Vetter
11.16.1 Vetter Company Detail
11.16.2 Vetter Business Overview
11.16.3 Vetter Small Molecule Drug CDMO Introduction
11.16.4 Vetter Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.16.5 Vetter Recent Development
11.17 Curia
11.17.1 Curia Company Detail
11.17.2 Curia Business Overview
11.17.3 Curia Small Molecule Drug CDMO Introduction
11.17.4 Curia Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.17.5 Curia Recent Development
11.18 Aenova
11.18.1 Aenova Company Detail
11.18.2 Aenova Business Overview
11.18.3 Aenova Small Molecule Drug CDMO Introduction
11.18.4 Aenova Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.18.5 Aenova Recent Development
11.19 Porton
11.19.1 Porton Company Detail
11.19.2 Porton Business Overview
11.19.3 Porton Small Molecule Drug CDMO Introduction
11.19.4 Porton Revenue in Small Molecule Drug CDMO Business (2018-2023)
11.19.5 Porton Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Small Molecule Drug CDMO Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of FDF CDMO
Table 3. Key Players of Packaging CDMO
Table 4. Key Players of Clinical CDMO
Table 5. Global Small Molecule Drug CDMO Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Small Molecule Drug CDMO Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Small Molecule Drug CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Small Molecule Drug CDMO Market Share by Region (2018-2023)
Table 9. Global Small Molecule Drug CDMO Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Small Molecule Drug CDMO Market Share by Region (2024-2033)
Table 11. Small Molecule Drug CDMO Market Trends
Table 12. Small Molecule Drug CDMO Market Drivers
Table 13. Small Molecule Drug CDMO Market Challenges
Table 14. Small Molecule Drug CDMO Market Restraints
Table 15. Global Small Molecule Drug CDMO Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Small Molecule Drug CDMO Market Share by Players (2018-2023)
Table 17. Global Top Small Molecule Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO as of 2022)
Table 18. Ranking of Global Top Small Molecule Drug CDMO Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Small Molecule Drug CDMO Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Small Molecule Drug CDMO Product Solution and Service
Table 22. Date of Enter into Small Molecule Drug CDMO Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Small Molecule Drug CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Small Molecule Drug CDMO Revenue Market Share by Type (2018-2023)
Table 26. Global Small Molecule Drug CDMO Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Small Molecule Drug CDMO Revenue Market Share by Type (2024-2033)
Table 28. Global Small Molecule Drug CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Small Molecule Drug CDMO Revenue Market Share by Application (2018-2023)
Table 30. Global Small Molecule Drug CDMO Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Small Molecule Drug CDMO Revenue Market Share by Application (2024-2033)
Table 32. North America Small Molecule Drug CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Small Molecule Drug CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Small Molecule Drug CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Small Molecule Drug CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Small Molecule Drug CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Small Molecule Drug CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Small Molecule Drug CDMO Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Small Molecule Drug CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Small Molecule Drug CDMO Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Small Molecule Drug CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Small Molecule Drug CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Small Molecule Drug CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Small Molecule Drug CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Small Molecule Drug CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Small Molecule Drug CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 47. Lonza Company Detail
Table 48. Lonza Business Overview
Table 49. Lonza Small Molecule Drug CDMO Product
Table 50. Lonza Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 51. Lonza Recent Development
Table 52. Catalent Company Detail
Table 53. Catalent Business Overview
Table 54. Catalent Small Molecule Drug CDMO Product
Table 55. Catalent Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 56. Catalent Recent Development
Table 57. Thermo Fisher Scientific Company Detail
Table 58. Thermo Fisher Scientific Business Overview
Table 59. Thermo Fisher Scientific Small Molecule Drug CDMO Product
Table 60. Thermo Fisher Scientific Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 61. Thermo Fisher Scientific Recent Development
Table 62. Samsung Biologics Company Detail
Table 63. Samsung Biologics Business Overview
Table 64. Samsung Biologics Small Molecule Drug CDMO Product
Table 65. Samsung Biologics Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 66. Samsung Biologics Recent Development
Table 67. Fareva Company Detail
Table 68. Fareva Business Overview
Table 69. Fareva Small Molecule Drug CDMO Product
Table 70. Fareva Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 71. Fareva Recent Development
Table 72. WuXi AppTech Company Detail
Table 73. WuXi AppTech Business Overview
Table 74. WuXi AppTech Small Molecule Drug CDMO Product
Table 75. WuXi AppTech Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 76. WuXi AppTech Recent Development
Table 77. WuXi Biologics Company Detail
Table 78. WuXi Biologics Business Overview
Table 79. WuXi Biologics Small Molecule Drug CDMO Product
Table 80. WuXi Biologics Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 81. WuXi Biologics Recent Development
Table 82. Siegfried Company Detail
Table 83. Siegfried Business Overview
Table 84. Siegfried Small Molecule Drug CDMO Product
Table 85. Siegfried Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 86. Siegfried Recent Development
Table 87. FUJIFILM Diosynth Biotechnologies Company Detail
Table 88. FUJIFILM Diosynth Biotechnologies Business Overview
Table 89. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product
Table 90. FUJIFILM Diosynth Biotechnologies Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 91. FUJIFILM Diosynth Biotechnologies Recent Development
Table 92. Asymchem Company Detail
Table 93. Asymchem Business Overview
Table 94. Asymchem Small Molecule Drug CDMO Product
Table 95. Asymchem Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 96. Asymchem Recent Development
Table 97. Pfizer CentreOne Company Detail
Table 98. Pfizer CentreOne Business Overview
Table 99. Pfizer CentreOne Small Molecule Drug CDMO Product
Table 100. Pfizer CentreOne Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 101. Pfizer CentreOne Recent Development
Table 102. Delpharm Company Detail
Table 103. Delpharm Business Overview
Table 104. Delpharm Small Molecule Drug CDMO Product
Table 105. Delpharm Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 106. Delpharm Recent Development
Table 107. Recipharm Company Detail
Table 108. Recipharm Business Overview
Table 109. Recipharm Small Molecule Drug CDMO Product
Table 110. Recipharm Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 111. Recipharm Recent Development
Table 112. AGC Pharma Chemicals Company Detail
Table 113. AGC Pharma Chemicals Business Overview
Table 114. AGC Pharma Chemicals Small Molecule Drug CDMO Product
Table 115. AGC Pharma Chemicals Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 116. AGC Pharma Chemicals Recent Development
Table 117. Boehringer Ingelheim Company Detail
Table 118. Boehringer Ingelheim Business Overview
Table 119. Boehringer Ingelheim Small Molecule Drug CDMO Product
Table 120. Boehringer Ingelheim Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 121. Boehringer Ingelheim Recent Development
Table 122. Vetter Company Detail
Table 123. Vetter Business Overview
Table 124. Vetter Small Molecule Drug CDMO Product
Table 125. Vetter Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 126. Vetter Recent Development
Table 127. Curia Company Detail
Table 128. Curia Business Overview
Table 129. Curia Small Molecule Drug CDMO Product
Table 130. Curia Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 131. Curia Recent Development
Table 132. Aenova Company Detail
Table 133. Aenova Business Overview
Table 134. Aenova Small Molecule Drug CDMO Product
Table 135. Aenova Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 136. Aenova Recent Development
Table 137. Porton Company Detail
Table 138. Porton Business Overview
Table 139. Porton Small Molecule Drug CDMO Product
Table 140. Porton Revenue in Small Molecule Drug CDMO Business (2018-2023) & (US$ Million)
Table 141. Porton Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Molecule Drug CDMO Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Small Molecule Drug CDMO Market Share by Type: 2022 VS 2033
Figure 3. FDF CDMO Features
Figure 4. Packaging CDMO Features
Figure 5. Clinical CDMO Features
Figure 6. Global Small Molecule Drug CDMO Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Small Molecule Drug CDMO Market Share by Application: 2022 VS 2033
Figure 8. Pharmaceutical Company Case Studies
Figure 9. Biotechnology Company Case Studies
Figure 10. Other Case Studies
Figure 11. Small Molecule Drug CDMO Report Years Considered
Figure 12. Global Small Molecule Drug CDMO Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Small Molecule Drug CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Small Molecule Drug CDMO Market Share by Region: 2022 VS 2033
Figure 15. Global Small Molecule Drug CDMO Market Share by Players in 2022
Figure 16. Global Top Small Molecule Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Small Molecule Drug CDMO Revenue in 2022
Figure 18. North America Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Small Molecule Drug CDMO Market Share by Country (2018-2033)
Figure 20. United States Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Small Molecule Drug CDMO Market Share by Country (2018-2033)
Figure 24. Germany Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Small Molecule Drug CDMO Market Share by Region (2018-2033)
Figure 32. China Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Small Molecule Drug CDMO Market Share by Country (2018-2033)
Figure 40. Mexico Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Small Molecule Drug CDMO Market Share by Country (2018-2033)
Figure 44. Turkey Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Small Molecule Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Lonza Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 47. Catalent Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 49. Samsung Biologics Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 50. Fareva Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 51. WuXi AppTech Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 52. WuXi Biologics Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 53. Siegfried Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 54. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 55. Asymchem Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 56. Pfizer CentreOne Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 57. Delpharm Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 58. Recipharm Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 59. AGC Pharma Chemicals Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 60. Boehringer Ingelheim Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 61. Vetter Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 62. Curia Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 63. Aenova Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 64. Porton Revenue Growth Rate in Small Molecule Drug CDMO Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries